James Paget
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
Papers in
- Surgery 8
- Orthopedic Surgery and Rehabilitation 5
- Reconstructive Surgery and Microvascular Techniques 3
-
- Cell death mechanisms and regulation 2
- Co-authors
- Kevin J. Harrington (7 shared papers)Holly E. Barker (3 shared papers)Aadil Khan (5 shared papers)Martin McLaughlin (5 shared papers)Magnus T. Dillon (3 shared papers)Henry Smith (4 shared papers)Malin Pedersen (2 shared papers)David Izadi (2 shared papers)
- Journals
- Journal of Plastic Reconstructive & Aesthetic Surgery (3 papers)Clinical Cancer Research (2 papers)Nature reviews. Cancer (2 papers)Molecular Cancer Therapeutics (1 paper)Science Translational Medicine (1 paper)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
James Paget
20 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Oncology 791
- Cancer Research 397
- Immunology 465
- Pulmonary and Respiratory Medicine 399
- Biomaterials 155
Countries citing papers authored by James Paget
This map shows the geographic impact of James Paget's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Paget with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Paget more than expected).
Fields of papers citing papers by James Paget
This network shows the impact of papers produced by James Paget. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Paget. The network helps show where James Paget may publish in the future.
Co-authors
The 25 scholars most cited alongside James Paget, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence Hit paper breakdown → | 2015 | 1605 |
| 2 | 2019 | 146 | |
| 3 | 2018 | 41 | |
| 4 | 2012 | 31 | |
| 5 | 2019 | 23 | |
| 6 | 2018 | 21 | |
| 7 | 2018 | 17 | |
| 8 | 2015 | 14 | |
| 9 | 2013 | 11 | |
| 10 | 2015 | 11 | |
| 11 | 2013 | 7 | |
| 12 | Memorials of the Craft of Surgery in England | 2008 | 4 |
| 13 | 2012 | 3 | |
| 14 | Selected Essays and Addresses | 2009 | 3 |
| 15 | 2018 | 2 | |
| 16 | 2013 | 2 | |
| 17 | 1982 | 2 | |
| 18 | 2018 | 1 | |
| 19 | 2015 | 1 | |
| 20 | 2013 | 1 |
About James Paget
James Paget is a scholar working on Surgery, Molecular Biology, Epidemiology, Oncology and Biotechnology, having authored 21 papers that have together received 1.9k indexed citations. Recurring topics across this work include Orthopedic Surgery and Rehabilitation (5 papers), Cancer Research and Treatments (3 papers), Bone fractures and treatments (3 papers), Reconstructive Surgery and Microvascular Techniques (3 papers), Virus-based gene therapy research (2 papers), Cell death mechanisms and regulation (2 papers), Primary Care and Health Outcomes (2 papers) and Soft tissue tumor case studies (1 paper). The work is most often cited by research in Oncology (791 citations), Cancer Research (397 citations), Immunology (465 citations), Pulmonary and Respiratory Medicine (399 citations) and Biomaterials (155 citations). James Paget has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Kevin J. Harrington, Holly E. Barker, Aadil Khan, Martin McLaughlin, Magnus T. Dillon, Henry Smith, Malin Pedersen, David Izadi, Umraz Khan and Alan Melcher. Their work appears in journals such as Journal of Plastic Reconstructive & Aesthetic Surgery, Clinical Cancer Research, Nature reviews. Cancer, Molecular Cancer Therapeutics and Science Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.